Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Valiant Laboratories Merger & Restructuring Worth ₹60 Cr

Valiant Laboratories will invest up to ₹60 Crore in its wholly-owned subsidiary, Valiant Advanced Sciences, through preference shares to support its capital base and operations.

Key figures
Value₹60.00 Cr
Execution period12 months
Source

NSE filing, NSE: VALIANTLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Valiant Laboratories Ltd: key numbers

Share price
₹118.46
Market cap
₹643.4 Cr
Revenue (annual)
₹237.5 Cr
Net profit (annual)
₹-3.27 Cr
P/E (TTM)
39.7×Sector 42.0×
Promoter holding
74.94%+0.00% QoQ
FII holding
0.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Valiant Laboratories Ltd

All →

Other merger & restructuring announcements

All →